Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p5
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 5/66)
Character Range: 12632–15723

entry for Cefotaxime [Authorised Prescriber: MP NP]
omit from the column headed "Circumstances": C5826 C5881 C5890  substitute: C15964 C16029 C16030
[36] Schedule 1, Part 1, entries for Ceftriaxone
substitute:
Ceftriaxone  Powder for injection 500 mg (as sodium)  Injection  Ceftriaxone‑AFT      AE  MP NP  C5855                 P5855                 1  0     1
Ceftriaxone  Powder for injection 500 mg (as sodium)  Injection  Ceftriaxone‑AFT      AE  MP NP  C15964 C16029 C16030  P15964 P16029 P16030  5  0     1
Ceftriaxone  Powder for injection 1 g (as sodium)     Injection  Ceftriaxone Viatris  AL  MP NP  C15964 C16029 C16030                        5  0     10
Ceftriaxone  Powder for injection 2 g (as sodium)     Injection  Ceftriaxone Viatris  AL  MP NP  C15964 C16029 C16030                        5  0     5
Ceftriaxone  Powder for injection 2 g (as sodium)     Injection  Ceftriaxone Viatris  AL  MP NP  C15964 C16029 C16030                        5  0     10

[37] Schedule 1, Part 1, entry for Ceritinib
omit from the column headed "Circumstances": C6732 C7369  substitute: C7346 C15759
[38] Schedule 1, Part 1, after entry for Chloramphenicol
insert:
Chlormethine  Gel 160 micrograms (as hydrochloride) per g, 60 g  Application  Ledaga  JZ  MP  C16054 C16145     2  5     1

[39] Schedule 1, Part 1, entry for Chlorpromazine in each of the forms: Injection containing chlorpromazine hydrochloride 50 mg in 2 mL; Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL; Tablet containing chlorpromazine hydrochloride 25 mg; and Tablet containing chlorpromazine hydrochloride 100 mg
insert in the column headed "Circumstances": C15956
[40] Schedule 1, Part 1, entry for Choriogonadotropin alfa in the form Solution for injection 250 micrograms in 0.5 mL pre-filled pen [Maximum Quantity: 1; Number of Repeats: 0]
insert in the column headed "Section 100/ Prescriber Bag only": C100
[41] Schedule 1, Part 1, after entry for Choriogonadotropin alfa in the form Solution for injection 250 micrograms in 0.5 mL pre-filled pen [Maximum Quantity: 4; Number of Repeats: 5]
insert:
Choriogonadotropin alfa  Solution for injection 250 micrograms in 0.5 mL pre-filled syringe (S19A)  Injection  Ovidrel (USA)  SG  MP  C14124  P14124  1  0     1     C(100)
Choriogonadotropin alfa  Solution for injection 250 micrograms in 0.5 mL pre-filled syringe (S19A)  Injection  Ovidrel (USA)  SG  MP  C14096  P14096  4  5     1

[42] Schedule 1, Part 1, entry for Ciprofloxacin in the form Tablet 250 mg (as hydrochloride)
omit:
Ciprofloxacin  Tablet 250 mg (as hydrochloride)  Oral  APX-Ciprofloxacin  TY  MP NP  C5614 C5615 C5666 C5687 C5688 C5689 C5722 C5780     14  0     14

[43] Schedule 1, Part 1, entry for Ciprofloxacin in the form Tablet 500 mg (as hydrochloride)
omit:
Ciprofloxacin  Tablet 500 mg (as hydrochloride)  Oral  APX-Ciprofloxacin  TY  MP NP  C5614 C5615 C5687 C5688 C5689 C5722 C5780     14  0     14

[44] Schedule 1, Part 1, entry for Ciprofloxacin in the form Tablet 750 mg (as hydrochloride)
omit:
Ciprofloxacin  Tablet 750 mg (as hydrochloride)  Oral